Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
25% Off Benzinga's Most Powerful Trading Tools
Traders Win More with Benzinga's Exclusive News and Squawk
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nephros
(NASDAQ:NEPH)
Intraday
$2.02
0.02
[1.00%]
After-Hours
$2.02
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.02
0.02
[1.00%]
At close: Apr 15
$2.02
0
[0.00%]
After Hours: 6:37PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Nephros Stock (NASDAQ:NEPH)
Nephros Stock (NASDAQ: NEPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 08, 2024
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target
Benzinga Newsdesk
-
Mar 8, 2024, 1:46PM
Thursday, March 07, 2024
Nephros: Q4 Earnings Insights
Benzinga Insights
-
Mar 7, 2024, 4:45PM
Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Benzinga Newsdesk
-
Mar 7, 2024, 4:42PM
Earnings Scheduled For March 7, 2024
Benzinga Insights
-
Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
Earnings Outlook For Nephros
Benzinga Insights
-
Mar 6, 2024, 1:02PM
Monday, February 26, 2024
11 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Feb 26, 2024, 12:31PM
Tuesday, December 26, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Dec 26, 2023, 12:31PM
Wednesday, December 13, 2023
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Dec 13, 2023, 1:40PM
Tuesday, December 12, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Dec 12, 2023, 12:31PM
Insiders Buying Delcath Systems And 3 Other Penny Stocks
Avi Kapoor
-
Dec 12, 2023, 8:21AM
Wednesday, November 08, 2023
Nephros: Q3 Earnings Insights
Benzinga Insights
-
Nov 8, 2023, 4:50PM
Nephros Q3 EPS $(0.02) Beats $(0.06) Estimate, Sales $3.74M Beat $3.35M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 4:49PM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Wednesday, November 01, 2023
Nephros Names Judy Krandel As CFO, Effective Today
Benzinga Newsdesk
-
Nov 1, 2023, 7:36AM
Tuesday, September 26, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Sep 26, 2023, 1:31PM
Thursday, August 10, 2023
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Aug 10, 2023, 1:31PM
Wednesday, August 09, 2023
Nephros Q2 EPS $(0.04) Beats $(0.05) Estimate, Sales $3.54M Beat $3.11M Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 4:20PM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Wednesday, June 14, 2023
11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jun 14, 2023, 9:08AM
Friday, June 02, 2023
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jun 2, 2023, 7:58AM
Thursday, June 01, 2023
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jun 1, 2023, 5:40PM
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Jun 1, 2023, 9:07AM
Wednesday, May 31, 2023
10 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
May 31, 2023, 1:32PM
Wednesday, May 10, 2023
Nephros: Q1 Earnings Insights
Benzinga Insights
-
May 10, 2023, 4:31PM
Nephros Q1 EPS $(0.03) Misses $(0.02) Estimate, Sales $3.70M Beat $3.68M Estimate
Benzinga Newsdesk
-
May 10, 2023, 4:25PM
Earnings Scheduled For May 10, 2023
Benzinga Insights
-
May 10, 2023, 9:12AM
Monday, May 08, 2023
Nephros CEO Andy Astor To Retire, Robert Banks To Be Named Successor
Benzinga Newsdesk
-
May 8, 2023, 7:32AM
Thursday, April 06, 2023
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Apr 6, 2023, 1:31PM
Tuesday, April 04, 2023
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Apr 4, 2023, 1:31PM
Nephros Sees Prelim. Q1 Revenue $3.7M, Up 69% YoY
Benzinga Newsdesk
-
Apr 4, 2023, 7:33AM
Wednesday, March 08, 2023
Nephros Q4 EPS $(0.07) Misses $(0.06) Estimate, Sales $2.56M Miss $2.80M Estimate
Benzinga Newsdesk
-
Mar 8, 2023, 4:30PM
Earnings Scheduled For March 8, 2023
Benzinga Insights
-
Mar 8, 2023, 4:42AM
Tuesday, March 07, 2023
Nephros's Earnings: A Preview
Benzinga Insights
-
Mar 7, 2023, 11:01AM
Wednesday, March 01, 2023
Nephros And Donastar Announce Strategic Partnership; Donastar Becomes Exclusive Master Distributor Of Nephros Commercial Water Filters For Food & Beverage And Hospitality Markets
Happy Mohamed
-
Mar 1, 2023, 5:07PM
Wednesday, January 11, 2023
Nephros Foresees 6% Revenue Decline In Q4
Shivani Kumaresan
-
Jan 11, 2023, 9:52AM
Nephros Reports Q4 Prelim. Sales Of ~$2.6M, FY22 Prelim. Sales Of ~$10M
Benzinga Newsdesk
-
Jan 11, 2023, 7:31AM
Friday, December 16, 2022
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 16, 2022, 12:32PM
Wednesday, November 02, 2022
Nephros Q3 EPS $(0.12) Misses $(0.11) Estimate, Sales $2.40M Miss $2.62M Estimate
Benzinga Newsdesk
-
Nov 2, 2022, 4:27PM
Earnings Scheduled For November 2, 2022
Benzinga Insights
-
Nov 2, 2022, 4:37AM
Tuesday, October 11, 2022
Nephros Sees Prelim. Revenues Of $2.5M For Quarter Ended Sept. 30 vs $2.83M Est.
Bill Haddad
-
Oct 11, 2022, 7:36AM
Nephros Announces Agreement to Sell Pathogen Detection Systems Business; Terms Not Disclosed
Bill Haddad
-
Oct 11, 2022, 7:34AM
Thursday, September 22, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 22, 2022, 2:17PM
Monday, September 19, 2022
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Sep 19, 2022, 5:38PM
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Sep 19, 2022, 12:30PM
Thursday, September 08, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 8, 2022, 12:08PM
Friday, September 02, 2022
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Sep 2, 2022, 1:56PM
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 2, 2022, 12:19PM
Thursday, September 01, 2022
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Sep 1, 2022, 5:40PM
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Sep 1, 2022, 2:08PM
Monday, August 29, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Aug 29, 2022, 11:50AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
